nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—Methotrexate—stomach cancer	0.656	1	CbGbCtD
Gadopentetate dimeglumine—PGD—Pentose Phosphate Pathway—PGLS—stomach cancer	0.0357	0.453	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—BLVRB—stomach cancer	0.00314	0.0398	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—PGLS—stomach cancer	0.00199	0.0252	CbGpPWpGaD
Gadopentetate dimeglumine—Gadobenate Dimeglumine—ALB—stomach cancer	0.00194	1	CrCbGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—FBP1—stomach cancer	0.00169	0.0214	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—hematopoietic system—stomach cancer	0.00156	0.185	CbGeAlD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—PGAM1—stomach cancer	0.00151	0.0191	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—TGFA—stomach cancer	0.00147	0.0186	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SERPINA1—stomach cancer	0.00144	0.0183	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—smooth muscle tissue—stomach cancer	0.00138	0.163	CbGeAlD
Gadopentetate dimeglumine—PGD—NRF2 pathway—CYP2A6—stomach cancer	0.00132	0.0167	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—lymphoid tissue—stomach cancer	0.0011	0.13	CbGeAlD
Gadopentetate dimeglumine—PGD—digestive system—stomach cancer	0.00109	0.128	CbGeAlD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—ALDOB—stomach cancer	0.00104	0.0132	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—HBEGF—stomach cancer	0.00104	0.0132	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—bone marrow—stomach cancer	0.001	0.118	CbGeAlD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTP1—stomach cancer	0.000926	0.0117	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—HMOX1—stomach cancer	0.000913	0.0116	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—endocrine gland—stomach cancer	0.000899	0.106	CbGeAlD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTM1—stomach cancer	0.000851	0.0108	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—liver—stomach cancer	0.000811	0.0957	CbGeAlD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—ENO1—stomach cancer	0.000792	0.01	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—CD44—stomach cancer	0.000702	0.00889	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ACAD8—stomach cancer	0.000698	0.00885	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GMPR2—stomach cancer	0.000622	0.00789	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—lymph node—stomach cancer	0.000622	0.0734	CbGeAlD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—PPP2R1A—stomach cancer	0.000597	0.00756	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SUCLG1—stomach cancer	0.000569	0.00721	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—IDH3B—stomach cancer	0.000569	0.00721	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PGLS—stomach cancer	0.000563	0.00714	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RBP1—stomach cancer	0.000537	0.00681	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NDUFV1—stomach cancer	0.000529	0.0067	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NDUFS1—stomach cancer	0.000529	0.0067	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FBP1—stomach cancer	0.000479	0.00607	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—BLVRB—stomach cancer	0.000472	0.00598	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PGLS—stomach cancer	0.000472	0.00598	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PPAP2A—stomach cancer	0.00045	0.0057	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PGAM1—stomach cancer	0.000427	0.00541	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—WIF1—stomach cancer	0.000407	0.00516	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—FBP1—stomach cancer	0.000401	0.00508	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NDUFA2—stomach cancer	0.000401	0.00508	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CKB—stomach cancer	0.000401	0.00508	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CA1—stomach cancer	0.000401	0.00508	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPL13—stomach cancer	0.000383	0.00485	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPL18—stomach cancer	0.000383	0.00485	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PLIN2—stomach cancer	0.000377	0.00478	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CA2—stomach cancer	0.000367	0.00465	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RNF43—stomach cancer	0.000363	0.0046	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PGAM1—stomach cancer	0.000358	0.00453	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NT5E—stomach cancer	0.000358	0.00453	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPS21—stomach cancer	0.000357	0.00452	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPS15—stomach cancer	0.000357	0.00452	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ALDH7A1—stomach cancer	0.000341	0.00432	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PLCE1—stomach cancer	0.000341	0.00432	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—UMPS—stomach cancer	0.000327	0.00414	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PDHA1—stomach cancer	0.000304	0.00385	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ECHS1—stomach cancer	0.000304	0.00385	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ALDOB—stomach cancer	0.000296	0.00375	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPL15—stomach cancer	0.00029	0.00368	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—FADS1—stomach cancer	0.000286	0.00362	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—TYMP—stomach cancer	0.000286	0.00362	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NPM1—stomach cancer	0.000285	0.00361	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RBP4—stomach cancer	0.000275	0.00348	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPS26—stomach cancer	0.000271	0.00343	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PPIA—stomach cancer	0.000268	0.0034	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SREBF2—stomach cancer	0.000268	0.00339	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—RORA—stomach cancer	0.000264	0.00335	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ALDOB—stomach cancer	0.000248	0.00314	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ALOX5—stomach cancer	0.00023	0.00292	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—AKR1C3—stomach cancer	0.00023	0.00291	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPS19—stomach cancer	0.00023	0.00291	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—DPYD—stomach cancer	0.000227	0.00287	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ENO1—stomach cancer	0.000224	0.00284	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPS6—stomach cancer	0.000203	0.00258	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTT1—stomach cancer	0.0002	0.00254	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CD44—stomach cancer	0.000199	0.00252	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP2A6—stomach cancer	0.000198	0.00251	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—AKR1C3—stomach cancer	0.000193	0.00244	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ENO1—stomach cancer	0.000188	0.00238	CbGpPWpGaD
Gadopentetate dimeglumine—Anorexia—Docetaxel—stomach cancer	0.000187	0.000735	CcSEcCtD
Gadopentetate dimeglumine—Shock—Capecitabine—stomach cancer	0.000187	0.000735	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—HBEGF—stomach cancer	0.000187	0.00237	CbGpPWpGaD
Gadopentetate dimeglumine—Rhinitis—Epirubicin—stomach cancer	0.000187	0.000734	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Doxorubicin—stomach cancer	0.000187	0.000734	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Capecitabine—stomach cancer	0.000186	0.000732	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Methotrexate—stomach cancer	0.000186	0.000731	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Fluorouracil—stomach cancer	0.000186	0.000731	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Methotrexate—stomach cancer	0.000186	0.00073	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Capecitabine—stomach cancer	0.000186	0.000729	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Methotrexate—stomach cancer	0.000185	0.000726	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Capecitabine—stomach cancer	0.000185	0.000725	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Doxorubicin—stomach cancer	0.000184	0.000724	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Epirubicin—stomach cancer	0.000184	0.000723	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Capecitabine—stomach cancer	0.000184	0.000722	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Epirubicin—stomach cancer	0.000184	0.000721	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Docetaxel—stomach cancer	0.000184	0.000721	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Epirubicin—stomach cancer	0.000183	0.00072	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Epirubicin—stomach cancer	0.000183	0.000718	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000182	0.000714	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Capecitabine—stomach cancer	0.000181	0.000712	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Methotrexate—stomach cancer	0.000181	0.00071	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Irinotecan—stomach cancer	0.000181	0.000709	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Methotrexate—stomach cancer	0.00018	0.000707	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Fluorouracil—stomach cancer	0.00018	0.000707	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Epirubicin—stomach cancer	0.00018	0.000706	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Methotrexate—stomach cancer	0.00018	0.000705	CcSEcCtD
Gadopentetate dimeglumine—Rash—Irinotecan—stomach cancer	0.000179	0.000704	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Irinotecan—stomach cancer	0.000179	0.000703	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000179	0.000703	CcSEcCtD
Gadopentetate dimeglumine—Chills—Methotrexate—stomach cancer	0.000179	0.000702	CcSEcCtD
Gadopentetate dimeglumine—Headache—Irinotecan—stomach cancer	0.000178	0.000699	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Capecitabine—stomach cancer	0.000178	0.000698	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Docetaxel—stomach cancer	0.000176	0.000693	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Epirubicin—stomach cancer	0.000176	0.000692	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Doxorubicin—stomach cancer	0.000176	0.00069	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Docetaxel—stomach cancer	0.000175	0.000688	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Docetaxel—stomach cancer	0.000175	0.000686	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Methotrexate—stomach cancer	0.000175	0.000686	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Epirubicin—stomach cancer	0.000174	0.000684	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Epirubicin—stomach cancer	0.000174	0.000683	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Methotrexate—stomach cancer	0.000173	0.000681	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000173	0.00068	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Epirubicin—stomach cancer	0.000173	0.00068	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Epirubicin—stomach cancer	0.000173	0.00068	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Fluorouracil—stomach cancer	0.000173	0.00068	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Doxorubicin—stomach cancer	0.000173	0.000679	CcSEcCtD
Gadopentetate dimeglumine—Rash—Fluorouracil—stomach cancer	0.000172	0.000674	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Fluorouracil—stomach cancer	0.000171	0.000673	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Capecitabine—stomach cancer	0.000171	0.000671	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Docetaxel—stomach cancer	0.000171	0.000671	CcSEcCtD
Gadopentetate dimeglumine—Headache—Fluorouracil—stomach cancer	0.00017	0.00067	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Doxorubicin—stomach cancer	0.00017	0.000669	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Doxorubicin—stomach cancer	0.00017	0.000668	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Methotrexate—stomach cancer	0.00017	0.000667	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00017	0.000666	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Doxorubicin—stomach cancer	0.00017	0.000666	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Capecitabine—stomach cancer	0.00017	0.000666	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Docetaxel—stomach cancer	0.000169	0.000665	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Epirubicin—stomach cancer	0.000169	0.000664	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Doxorubicin—stomach cancer	0.000169	0.000664	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—PPP2R1A—stomach cancer	0.000169	0.00214	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Irinotecan—stomach cancer	0.000169	0.000663	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Epirubicin—stomach cancer	0.000168	0.000661	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Epirubicin—stomach cancer	0.000168	0.00066	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Docetaxel—stomach cancer	0.000168	0.00066	CcSEcCtD
Gadopentetate dimeglumine—Pain—Docetaxel—stomach cancer	0.000168	0.00066	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Methotrexate—stomach cancer	0.000168	0.000659	CcSEcCtD
Gadopentetate dimeglumine—Chills—Epirubicin—stomach cancer	0.000167	0.000657	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Epirubicin—stomach cancer	0.000167	0.000654	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CD44—stomach cancer	0.000167	0.00211	CbGpPWpGaD
Gadopentetate dimeglumine—Visual impairment—Doxorubicin—stomach cancer	0.000166	0.000653	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Capecitabine—stomach cancer	0.000165	0.000649	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000164	0.000645	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Capecitabine—stomach cancer	0.000164	0.000644	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Epirubicin—stomach cancer	0.000163	0.000642	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Doxorubicin—stomach cancer	0.000163	0.000641	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Capecitabine—stomach cancer	0.000163	0.000639	CcSEcCtD
Gadopentetate dimeglumine—Pain—Capecitabine—stomach cancer	0.000163	0.000639	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Epirubicin—stomach cancer	0.000162	0.000638	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Docetaxel—stomach cancer	0.000162	0.000636	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Fluorouracil—stomach cancer	0.000162	0.000635	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Doxorubicin—stomach cancer	0.000161	0.000633	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Doxorubicin—stomach cancer	0.000161	0.000632	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000161	0.000631	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Doxorubicin—stomach cancer	0.00016	0.000629	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Doxorubicin—stomach cancer	0.00016	0.000629	CcSEcCtD
Gadopentetate dimeglumine—Tension—Epirubicin—stomach cancer	0.000159	0.000626	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Epirubicin—stomach cancer	0.000159	0.000624	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—SMAD4—stomach cancer	0.000157	0.00199	CbGpPWpGaD
Gadopentetate dimeglumine—Back pain—Epirubicin—stomach cancer	0.000157	0.000617	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Capecitabine—stomach cancer	0.000157	0.000615	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Doxorubicin—stomach cancer	0.000157	0.000615	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Methotrexate—stomach cancer	0.000156	0.000614	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Doxorubicin—stomach cancer	0.000156	0.000612	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000155	0.000611	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000155	0.000611	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Docetaxel—stomach cancer	0.000155	0.00061	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Docetaxel—stomach cancer	0.000155	0.00061	CcSEcCtD
Gadopentetate dimeglumine—Chills—Doxorubicin—stomach cancer	0.000155	0.000608	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Doxorubicin—stomach cancer	0.000154	0.000605	CcSEcCtD
Gadopentetate dimeglumine—Cough—Methotrexate—stomach cancer	0.000151	0.000594	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Doxorubicin—stomach cancer	0.000151	0.000594	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Capecitabine—stomach cancer	0.000151	0.000593	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Capecitabine—stomach cancer	0.00015	0.00059	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Capecitabine—stomach cancer	0.00015	0.00059	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Methotrexate—stomach cancer	0.00015	0.00059	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Doxorubicin—stomach cancer	0.00015	0.00059	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Epirubicin—stomach cancer	0.000149	0.000586	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—FYN—stomach cancer	0.000149	0.00189	CbGpPWpGaD
Gadopentetate dimeglumine—Arthralgia—Methotrexate—stomach cancer	0.000148	0.00058	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Methotrexate—stomach cancer	0.000148	0.00058	CcSEcCtD
Gadopentetate dimeglumine—Tension—Doxorubicin—stomach cancer	0.000147	0.000579	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Doxorubicin—stomach cancer	0.000147	0.000578	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000147	0.000576	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Epirubicin—stomach cancer	0.000146	0.000575	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Epirubicin—stomach cancer	0.000146	0.000572	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Doxorubicin—stomach cancer	0.000145	0.000571	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Docetaxel—stomach cancer	0.000145	0.000568	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—ERCC2—stomach cancer	0.000143	0.00182	CbGpPWpGaD
Gadopentetate dimeglumine—Confusional state—Methotrexate—stomach cancer	0.000143	0.000561	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Epirubicin—stomach cancer	0.000143	0.00056	CcSEcCtD
Gadopentetate dimeglumine—Cough—Epirubicin—stomach cancer	0.000142	0.000556	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PPP2R1A—stomach cancer	0.000142	0.00179	CbGpPWpGaD
Gadopentetate dimeglumine—Anaphylactic shock—Methotrexate—stomach cancer	0.000142	0.000556	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Docetaxel—stomach cancer	0.000141	0.000553	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Epirubicin—stomach cancer	0.000141	0.000552	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Epirubicin—stomach cancer	0.00014	0.00055	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Capecitabine—stomach cancer	0.00014	0.00055	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—FGFR2—stomach cancer	0.00014	0.00177	CbGpPWpGaD
Gadopentetate dimeglumine—Pruritus—Docetaxel—stomach cancer	0.000139	0.000546	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—GSTP1—stomach cancer	0.000139	0.00176	CbGpPWpGaD
Gadopentetate dimeglumine—Nervous system disorder—Methotrexate—stomach cancer	0.000139	0.000545	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Epirubicin—stomach cancer	0.000138	0.000543	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Epirubicin—stomach cancer	0.000138	0.000543	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Doxorubicin—stomach cancer	0.000138	0.000542	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Epirubicin—stomach cancer	0.000138	0.000541	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Methotrexate—stomach cancer	0.000138	0.00054	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000137	0.000539	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—HMOX1—stomach cancer	0.000137	0.00174	CbGpPWpGaD
Gadopentetate dimeglumine—Hyperhidrosis—Methotrexate—stomach cancer	0.000137	0.000537	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Capecitabine—stomach cancer	0.000136	0.000536	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Doxorubicin—stomach cancer	0.000135	0.000532	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Epirubicin—stomach cancer	0.000135	0.000531	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Methotrexate—stomach cancer	0.000135	0.00053	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—MTHFR—stomach cancer	0.000135	0.00171	CbGpPWpGaD
Gadopentetate dimeglumine—Syncope—Doxorubicin—stomach cancer	0.000135	0.000529	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Capecitabine—stomach cancer	0.000135	0.000528	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Docetaxel—stomach cancer	0.000134	0.000528	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Epirubicin—stomach cancer	0.000134	0.000525	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Epirubicin—stomach cancer	0.000132	0.00052	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Methotrexate—stomach cancer	0.000132	0.00052	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Doxorubicin—stomach cancer	0.000132	0.000518	CcSEcCtD
Gadopentetate dimeglumine—Cough—Doxorubicin—stomach cancer	0.000131	0.000515	CcSEcCtD
Gadopentetate dimeglumine—Shock—Epirubicin—stomach cancer	0.00013	0.000512	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Doxorubicin—stomach cancer	0.00013	0.000511	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Capecitabine—stomach cancer	0.00013	0.000511	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Epirubicin—stomach cancer	0.00013	0.00051	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Docetaxel—stomach cancer	0.00013	0.00051	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Doxorubicin—stomach cancer	0.00013	0.000509	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Epirubicin—stomach cancer	0.000129	0.000508	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—TYMS—stomach cancer	0.000129	0.00164	CbGpPWpGaD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000129	0.000507	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Epirubicin—stomach cancer	0.000129	0.000505	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—IRS2—stomach cancer	0.000128	0.00162	CbGpPWpGaD
Gadopentetate dimeglumine—Hyperhidrosis—Epirubicin—stomach cancer	0.000128	0.000503	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Doxorubicin—stomach cancer	0.000128	0.000502	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Doxorubicin—stomach cancer	0.000128	0.000502	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—GSTM1—stomach cancer	0.000128	0.00162	CbGpPWpGaD
Gadopentetate dimeglumine—Anxiety—Doxorubicin—stomach cancer	0.000127	0.0005	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Methotrexate—stomach cancer	0.000127	0.000499	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000127	0.000499	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Epirubicin—stomach cancer	0.000126	0.000496	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Methotrexate—stomach cancer	0.000126	0.000496	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Methotrexate—stomach cancer	0.000126	0.000494	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Capecitabine—stomach cancer	0.000126	0.000494	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Doxorubicin—stomach cancer	0.000125	0.000491	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Docetaxel—stomach cancer	0.000125	0.00049	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CAV1—stomach cancer	0.000124	0.00157	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—APOA1—stomach cancer	0.000124	0.00157	CbGpPWpGaD
Gadopentetate dimeglumine—Rash—Docetaxel—stomach cancer	0.000124	0.000486	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Epirubicin—stomach cancer	0.000124	0.000486	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Docetaxel—stomach cancer	0.000124	0.000486	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Doxorubicin—stomach cancer	0.000124	0.000485	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Methotrexate—stomach cancer	0.000123	0.000483	CcSEcCtD
Gadopentetate dimeglumine—Headache—Docetaxel—stomach cancer	0.000123	0.000483	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000123	0.000481	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000122	0.00048	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Methotrexate—stomach cancer	0.000122	0.000479	CcSEcCtD
Gadopentetate dimeglumine—Pain—Methotrexate—stomach cancer	0.000121	0.000475	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Capecitabine—stomach cancer	0.000121	0.000475	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000121	0.000474	CcSEcCtD
Gadopentetate dimeglumine—Shock—Doxorubicin—stomach cancer	0.000121	0.000474	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Doxorubicin—stomach cancer	0.00012	0.000472	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—ERCC2—stomach cancer	0.00012	0.00152	CbGpPWpGaD
Gadopentetate dimeglumine—Rash—Capecitabine—stomach cancer	0.00012	0.000471	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Capecitabine—stomach cancer	0.00012	0.00047	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Doxorubicin—stomach cancer	0.00012	0.00047	CcSEcCtD
Gadopentetate dimeglumine—Headache—Capecitabine—stomach cancer	0.000119	0.000468	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Doxorubicin—stomach cancer	0.000119	0.000468	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Epirubicin—stomach cancer	0.000119	0.000467	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000118	0.000465	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Epirubicin—stomach cancer	0.000118	0.000464	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—IL6ST—stomach cancer	0.000118	0.00149	CbGpPWpGaD
Gadopentetate dimeglumine—Somnolence—Epirubicin—stomach cancer	0.000118	0.000463	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Doxorubicin—stomach cancer	0.000117	0.000459	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Docetaxel—stomach cancer	0.000117	0.000458	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Methotrexate—stomach cancer	0.000117	0.000458	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000116	0.000455	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Epirubicin—stomach cancer	0.000115	0.000452	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Doxorubicin—stomach cancer	0.000115	0.00045	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000114	0.000449	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Epirubicin—stomach cancer	0.000114	0.000449	CcSEcCtD
Gadopentetate dimeglumine—Pain—Epirubicin—stomach cancer	0.000113	0.000445	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Epirubicin—stomach cancer	0.000113	0.000445	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—APC—stomach cancer	0.000113	0.00143	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Capecitabine—stomach cancer	0.000113	0.000444	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—MTHFR—stomach cancer	0.000113	0.00143	CbGpPWpGaD
Gadopentetate dimeglumine—Urticaria—Methotrexate—stomach cancer	0.000112	0.000442	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Methotrexate—stomach cancer	0.000112	0.00044	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Methotrexate—stomach cancer	0.000112	0.00044	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000112	0.000439	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Doxorubicin—stomach cancer	0.00011	0.000432	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Doxorubicin—stomach cancer	0.000109	0.000429	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Epirubicin—stomach cancer	0.000109	0.000429	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Doxorubicin—stomach cancer	0.000109	0.000428	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000108	0.000425	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Doxorubicin—stomach cancer	0.000107	0.000418	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000106	0.000416	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Doxorubicin—stomach cancer	0.000106	0.000415	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Epirubicin—stomach cancer	0.000105	0.000413	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—IL6R—stomach cancer	0.000105	0.00133	CbGpPWpGaD
Gadopentetate dimeglumine—Pain—Doxorubicin—stomach cancer	0.000105	0.000412	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Doxorubicin—stomach cancer	0.000105	0.000412	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Epirubicin—stomach cancer	0.000105	0.000411	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Epirubicin—stomach cancer	0.000105	0.000411	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Methotrexate—stomach cancer	0.000104	0.00041	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CAV1—stomach cancer	0.000104	0.00132	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—APOA1—stomach cancer	0.000104	0.00132	CbGpPWpGaD
Gadopentetate dimeglumine—Asthenia—Methotrexate—stomach cancer	0.000102	0.000399	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Doxorubicin—stomach cancer	0.000101	0.000397	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.0001	0.000394	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Methotrexate—stomach cancer	0.0001	0.000393	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—SERPINE1—stomach cancer	9.84e-05	0.00125	CbGpPWpGaD
Gadopentetate dimeglumine—Hypersensitivity—Epirubicin—stomach cancer	9.76e-05	0.000383	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Doxorubicin—stomach cancer	9.74e-05	0.000382	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Doxorubicin—stomach cancer	9.69e-05	0.000381	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Doxorubicin—stomach cancer	9.69e-05	0.000381	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Methotrexate—stomach cancer	9.69e-05	0.00038	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Epirubicin—stomach cancer	9.5e-05	0.000373	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—RHOA—stomach cancer	9.49e-05	0.0012	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NOS3—stomach cancer	9.4e-05	0.00119	CbGpPWpGaD
Gadopentetate dimeglumine—Pruritus—Epirubicin—stomach cancer	9.37e-05	0.000368	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Methotrexate—stomach cancer	9.36e-05	0.000368	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PPARG—stomach cancer	9.15e-05	0.00116	CbGpPWpGaD
Gadopentetate dimeglumine—Diarrhoea—Epirubicin—stomach cancer	9.06e-05	0.000356	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Doxorubicin—stomach cancer	9.03e-05	0.000355	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Methotrexate—stomach cancer	9e-05	0.000353	CcSEcCtD
Gadopentetate dimeglumine—Rash—Methotrexate—stomach cancer	8.93e-05	0.000351	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Methotrexate—stomach cancer	8.92e-05	0.00035	CcSEcCtD
Gadopentetate dimeglumine—Headache—Methotrexate—stomach cancer	8.87e-05	0.000348	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Doxorubicin—stomach cancer	8.79e-05	0.000345	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—ERBB2—stomach cancer	8.79e-05	0.00111	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Epirubicin—stomach cancer	8.76e-05	0.000344	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Doxorubicin—stomach cancer	8.67e-05	0.000341	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—PTGS2—stomach cancer	8.59e-05	0.00109	CbGpPWpGaD
Gadopentetate dimeglumine—Vomiting—Epirubicin—stomach cancer	8.42e-05	0.000331	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Methotrexate—stomach cancer	8.41e-05	0.00033	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Doxorubicin—stomach cancer	8.39e-05	0.000329	CcSEcCtD
Gadopentetate dimeglumine—Rash—Epirubicin—stomach cancer	8.35e-05	0.000328	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Epirubicin—stomach cancer	8.35e-05	0.000328	CcSEcCtD
Gadopentetate dimeglumine—Headache—Epirubicin—stomach cancer	8.3e-05	0.000326	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—ALB—stomach cancer	8.23e-05	0.00104	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CDKN1B—stomach cancer	8.14e-05	0.00103	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Doxorubicin—stomach cancer	8.11e-05	0.000318	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Epirubicin—stomach cancer	7.87e-05	0.000309	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—NOS3—stomach cancer	7.87e-05	0.000997	CbGpPWpGaD
Gadopentetate dimeglumine—Vomiting—Doxorubicin—stomach cancer	7.79e-05	0.000306	CcSEcCtD
Gadopentetate dimeglumine—Rash—Doxorubicin—stomach cancer	7.73e-05	0.000304	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Doxorubicin—stomach cancer	7.72e-05	0.000303	CcSEcCtD
Gadopentetate dimeglumine—Headache—Doxorubicin—stomach cancer	7.68e-05	0.000302	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CDKN1A—stomach cancer	7.51e-05	0.000952	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Doxorubicin—stomach cancer	7.28e-05	0.000286	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PTGS2—stomach cancer	7.2e-05	0.000912	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—STAT3—stomach cancer	6.7e-05	0.000849	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MAPK3—stomach cancer	6.4e-05	0.000811	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MYC—stomach cancer	6.23e-05	0.000789	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MAPK1—stomach cancer	6.09e-05	0.000772	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—EGFR—stomach cancer	6.09e-05	0.000772	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—KRAS—stomach cancer	5.75e-05	0.000729	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PIK3CA—stomach cancer	5.29e-05	0.00067	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HRAS—stomach cancer	4.89e-05	0.00062	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—IL6—stomach cancer	4.68e-05	0.000593	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CA—stomach cancer	4.43e-05	0.000561	CbGpPWpGaD
